Cargando…
Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
Nasopharyngeal cancer shows a good response to intensity-modulated radiotherapy. However, there is no clear evidence for the benefits of routine use of image-guided radiotherapy. The purpose of this study was to perform a retrospective investigation of the treatment outcomes, treatment-related compl...
Autores principales: | Yeh, Shyh-An, Hwang, Tzer-Zen, Wang, Chih-Chun, Yang, Chuen-Chien, Lien, Ching-Feng, Wang, Chien-Chung, Hsu, Tun-Yen, Hsu, Ruey-Feng, Shih, Yu-Chen, Huang, Yaw-Chang, Hsieh, Meng-Che, Gau, Jhy-Shyan, Chang, Liyun, Lee, Tsair-Fwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127674/ https://www.ncbi.nlm.nih.gov/pubmed/33783535 http://dx.doi.org/10.1093/jrr/rrab008 |
Ejemplares similares
-
Impact of Parenteral Glutamine Supplement on Oncologic Outcomes in Patients with Nasopharyngeal Cancer Treated with Concurrent Chemoradiotherapy
por: Wang, Chih-Chun, et al.
Publicado: (2022) -
Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis
por: Lien, Ching-Feng, et al.
Publicado: (2022) -
Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis
por: Hsieh, Meng-Che, et al.
Publicado: (2021) -
Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa
por: Yang, Chuan-Chien, et al.
Publicado: (2022) -
The Impact of Insurance and Marital Status on Survival in Patients with Nasopharyngeal Carcinoma
por: Wang, Chih-Chun, et al.
Publicado: (2020)